Xxera/openscience/retractions

Record #56008

Identifying and Verifying AR, ERBB2, and VEGFA Are the Targets of Qigesan in the Treatment of Esophageal Adenocarcinoma In Silico and In Vitro

Dong Zhang, Lang Guo, Xiaoting Wu, Meng Luo, Xinyi Liang, Cheng Jiang, Tao Wang, Yong Gao, Qiuping Zou

Journal

Scientific Programming

Publisher

Original paper date

Aug 25, 2021

Original DOI

10.1155/2021/5463724

Country

Institution

Science and Technology Innovation Center of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510000, China · The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510000, China · Department of Operating Theatre, Binzhou People’s Hospital, Binzhou 256600, China · The First Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510000, China · Emergency Department, Dongguan People’s Hospital, Dongguan 523000, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (HSC) Medicine - Alternative (HSC) Medicine - Oncology (HSC) Medicine - Otorhinolaryngology (HSC) Medicine - Pharmacology

Notes from Retraction Watch

See also: https://pubpeer.com/publications/2A824AF03652116B4DEB8685F83C40

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

1

Post-retraction

0

% post-retraction

0.0%

~0.0 citations/yr before retraction · ~0.0 citations/yr after

— citing papers

Who is still citing this work

Loading…